Long Circulating Liposomes: Old Drugs, New Therapeutics
(Sprache: Englisch)
This book provides an up-to-date evaluation of clinical aspects of newly available "long-circulating liposome" formulations. Based on results from numerous clinical studies, the book describes the fundamentals of this new technology, discusses how it may...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
109.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Long Circulating Liposomes: Old Drugs, New Therapeutics “
Klappentext zu „Long Circulating Liposomes: Old Drugs, New Therapeutics “
This book provides an up-to-date evaluation of clinical aspects of newly available "long-circulating liposome" formulations. Based on results from numerous clinical studies, the book describes the fundamentals of this new technology, discusses how it may influence the pharmacology of existing well-known agents reformulated in this manner, and elaborates on future expectations. It provides the practicing clinician - in particular, oncologists and critical care infectious disease physicians - with the tools needed to use these new formulations towards the best outcome for the patient.
Inhaltsverzeichnis zu „Long Circulating Liposomes: Old Drugs, New Therapeutics “
1. Long Circulating Liposome Therapeutics: From Concept to Clinical Reality.- 2. Oncologic Agents in Sterically Stabilized Liposomes: Basic Considerations.- 3. Liposomal Vincristine: The Central Role of Drug Retention in Defining Therapeutically Optimized Anticancer Formulations.- 4. Long Circulating Liposome-Encapsulated Tumor Necrosis Factor in the Treatment of Solid Tumors.- 5. Therapy of Human Carcinoma Xenografts with Doxorubicin Encapsulated in Sterically Stabilized Liposomes (DOXIL®): Efficacy and Safety Studies.- 6. Design and Development of Long Circulating Liposomal Daunorubicin for In Vivo Targeting of Solid Tumors: DaunoXome®.- 7. Enhancement of Doxorubicin by Encapsulation in Long circulating Thermosensitive Liposomes Combined with Local Hyperthermia.- 8. Liposomal Localization and Chemotherapy for AIDS-Related Kaposi's Sarcoma.- 9. Pegylated-Liposomal Doxorubicin (Doxil®) in the Treatment of AIDS-Related Kaposi's Sarcoma.- 10. DaunoXome® (Liposomal Daunorubicin) for First-Line Treatment of Advanced, HIV-Related Kaposi's Sarcoma.- 11. Initial Clinical Evaluation of Pegylated-Liposomal Doxorubicin in Solid Tumors.- 12. Antibacterial Therapy with Sterically Stabilized Liposome Formulations.- 13. AmBisome®: Long Circulating Liposomal Formulation of Amphotericin B.- 14. Steric Stabilization of Liposomes Containing Amphotericin B: A Future Direction in Antifungal Therapy?.- 15. Clinical and Preclinical Studies with Low-Clearance Liposomal Amikacin (MiKasome®).- 16. Sterically Stabilized Liposomes to Image Infection and Inflammation.- 17. Long Circulating Liposomes for Diagnostic Imaging.- 18. Tumor Imaging with Long Circulating Liposomes.- 19. Antibody-Mediated Targeting of PEG-Coated Liposomes.- 20. Small Molecule Ligands for Targeting LongCirculating Liposomes.
Autoren-Porträt
An up-to-date evaluation of clinical aspects of newly available "long-circulating liposome" formulations - a new technology, which will influence the pharmacology of existing well-known agents.
Bibliographische Angaben
- 2013, Softcover reprint of the original 1st ed. 1998, XX, 301 Seiten, Maße: 15,5 x 23,5 cm, Kartoniert (TB), Englisch
- Herausgegeben: Martin C. Woodle, Gerrit Storm
- Verlag: Springer, Berlin
- ISBN-10: 3662221179
- ISBN-13: 9783662221174
Sprache:
Englisch
Kommentar zu "Long Circulating Liposomes: Old Drugs, New Therapeutics"
Schreiben Sie einen Kommentar zu "Long Circulating Liposomes: Old Drugs, New Therapeutics".
Kommentar verfassen